Mauritius to impose regressive mark-up on 550 pharmaceutical products

The Ministry of Commerce and Consumer Protection will soon apply a regressive mark-up mechanism on eight out of eleven classes of pharmaceutical products. These are Biologicals, Anti-cancer, Anti-diabetic, Anti- hypertensive, cardiovascular, Inhaler, Vaccine and Anti-acid comprising more than 550 pharmaceutical products.

It will also apply a 30% maximum mark-up for all remaining pharmaceutical products, including the most consumed brands/classes of medicines.

Furthermore, the Ministry will be conducting another assessment in July 2023, “to ensure that the impact on the retail prices of the pharmaceutical products have been adjusted to the market forces and further consider inclusion or exclusion of classes under the regressive mark-up mechanism”.

Source: Mauritius Cabinet Papers